Advertisement
Screener

EDITAS MEDICINE, INC. (EDIT) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

EDITAS MEDICINE, INC. Increase (Decrease) in Prepaid Expense and Other Assets

EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05

  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.87M, a 283.40% increase year-over-year.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$248.00K.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$887.00K.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$593.00K.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.06M.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$4.40M, a 2331.47% decline from fiscal 2023.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $197.00K, a 43.80% increase from fiscal 2022.
  • EDITAS MEDICINE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $137.00K.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$1.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$1.62M
10-Q · filed 2026-08-05
$736.00K
derived: sum of 3 quarters · filed 2026-08-05
$143.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$248.00K
10-Q · filed 2026-05-05
-$1.14M
derived: sum of 2 quarters · filed 2026-05-05
-$1.73M
derived: sum of 3 quarters · filed 2026-05-05
-$1.24M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$887.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$1.48M
derived: sum of 2 quarters · filed 2026-03-09
-$992.00K
derived: sum of 3 quarters · filed 2026-08-05
-$1.06M
10-K · filed 2026-03-09
2025-09-30-$593.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$105.00K
derived: sum of 2 quarters · filed 2026-08-05
-$175.00K
10-Q · filed 2025-11-10
-$2.96M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$488.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$418.00K
10-Q · filed 2026-08-05
-$2.37M
derived: sum of 3 quarters · filed 2026-08-05
-$3.44M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$70.00K
10-Q · filed 2026-05-05
-$2.86M
derived: sum of 2 quarters · filed 2026-05-05
-$3.93M
derived: sum of 3 quarters · filed 2026-05-05
-$6.07M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
-$3.86M
derived: sum of 2 quarters · filed 2026-03-09
-$6.00M
derived: sum of 3 quarters · filed 2026-03-09
-$4.40M
10-K · filed 2026-03-09
2024-09-30-$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$3.21M
derived: sum of 2 quarters · filed 2025-11-10
-$1.61M
10-Q · filed 2025-11-10
-$639.00K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$2.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$535.00K
10-Q · filed 2025-08-12
$433.00K
derived: sum of 3 quarters · filed 2025-08-12
$273.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$1.61M
10-Q · filed 2025-05-12
$2.58M
derived: sum of 2 quarters · filed 2025-05-12
$2.42M
derived: sum of 3 quarters · filed 2025-05-12
$3.36M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$968.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$808.00K
derived: sum of 2 quarters · filed 2025-03-05
$1.75M
derived: sum of 3 quarters · filed 2025-03-05
$197.00K
10-K · filed 2025-03-05
2023-09-30-$160.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
$787.00K
derived: sum of 2 quarters · filed 2024-11-04
-$771.00K
10-Q · filed 2024-11-04
-$327.00K
derived: sum of 4 quarters · filed 2025-03-05
2023-06-30$947.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$611.00K
10-Q · filed 2024-08-07
-$167.00K
derived: sum of 3 quarters · filed 2025-03-05
-$1.38M
derived: sum of 4 quarters · filed 2025-03-05
2023-03-31-$1.56M
10-Q · filed 2024-05-08
-$1.11M
derived: sum of 2 quarters · filed 2025-03-05
-$2.33M
derived: sum of 3 quarters · filed 2025-03-05
-$1.52M
derived: sum of 4 quarters · filed 2025-03-05
2022-12-31$444.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
-$771.00K
derived: sum of 2 quarters · filed 2025-03-05
$38.00K
derived: sum of 3 quarters · filed 2025-03-05
$137.00K
10-K · filed 2025-03-05
2022-09-30-$1.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
-$406.00K
derived: sum of 2 quarters · filed 2023-11-03
-$307.00K
10-Q · filed 2023-11-03
-$2.62M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$809.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$908.00K
10-Q · filed 2023-08-02
-$1.41M
derived: sum of 3 quarters · filed 2024-02-28
$2.70M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$99.00K
10-Q · filed 2023-05-05
-$2.22M
derived: sum of 2 quarters · filed 2024-02-28
$1.89M
derived: sum of 3 quarters · filed 2024-02-28
$986.00K
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$2.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$1.79M
derived: sum of 2 quarters · filed 2024-02-28
$887.00K
derived: sum of 3 quarters · filed 2024-02-28
-$3.73M
10-K · filed 2024-02-28
2021-09-30$4.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$3.20M
derived: sum of 2 quarters · filed 2022-11-02
-$1.41M
10-Q · filed 2022-11-02
-$952.00K
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30-$903.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$5.52M
10-Q · filed 2022-08-03
-$5.06M
derived: sum of 3 quarters · filed 2023-02-22
-$4.13M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31-$4.62M
10-Q · filed 2022-05-04
-$4.16M
derived: sum of 2 quarters · filed 2023-02-22
-$3.23M
derived: sum of 3 quarters · filed 2023-02-22
-$1.97M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$462.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$1.39M
derived: sum of 2 quarters · filed 2023-02-22
$2.65M
derived: sum of 3 quarters · filed 2023-02-22
$4.64M
10-K · filed 2023-02-22
2020-09-30$927.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$2.19M
derived: sum of 2 quarters · filed 2021-11-09
$4.18M
10-Q · filed 2021-11-09
$4.94M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$3.25M
10-Q · filed 2021-08-05
$4.01M
derived: sum of 3 quarters · filed 2022-02-24
$4.05M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$2.00M
10-Q · filed 2021-05-06
$2.75M
derived: sum of 2 quarters · filed 2022-02-24
$2.79M
derived: sum of 3 quarters · filed 2022-02-24
$3.28M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$758.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$796.00K
derived: sum of 2 quarters · filed 2022-02-24
$1.28M
derived: sum of 3 quarters · filed 2022-02-24
$495.00K
10-K · filed 2022-02-24
2019-09-30$38.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$526.00K
derived: sum of 2 quarters · filed 2020-11-06
-$263.00K
10-Q · filed 2020-11-06
$798.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$488.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$301.00K
10-Q · filed 2020-08-07
$760.00K
derived: sum of 3 quarters · filed 2021-02-26
$1.70M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$789.00K
10-Q · filed 2020-05-08
$272.00K
derived: sum of 2 quarters · filed 2021-02-26
$1.21M
derived: sum of 3 quarters · filed 2021-02-26
$1.86M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$2.00M
derived: sum of 2 quarters · filed 2021-02-26
$2.65M
derived: sum of 3 quarters · filed 2021-02-26
$3.41M
10-K · filed 2021-02-26
2018-09-30$935.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.59M
derived: sum of 2 quarters · filed 2019-11-12
$2.35M
10-Q · filed 2019-11-12
$2.69M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$653.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$1.41M
10-Q · filed 2019-08-07
$1.75M
derived: sum of 3 quarters · filed 2020-02-26
$1.52M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$761.00K
10-Q · filed 2019-05-08
$1.10M
derived: sum of 2 quarters · filed 2020-02-26
$871.00K
derived: sum of 3 quarters · filed 2020-02-26
$1.84M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$338.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$110.00K
derived: sum of 2 quarters · filed 2020-02-26
$1.08M
derived: sum of 3 quarters · filed 2020-02-26
$596.00K
10-K · filed 2020-02-26
2017-09-30-$228.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$744.00K
derived: sum of 2 quarters · filed 2018-11-08
$258.00K
10-Q · filed 2018-11-08
-$103.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$972.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$486.00K
10-Q · filed 2018-08-07
$125.00K
derived: sum of 3 quarters · filed 2019-03-01
$205.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$486.00K
10-Q · filed 2018-05-04
-$847.00K
derived: sum of 2 quarters · filed 2019-03-01
-$767.00K
derived: sum of 3 quarters · filed 2019-03-01
-$268.00K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$361.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$281.00K
derived: sum of 2 quarters · filed 2019-03-01
$218.00K
derived: sum of 3 quarters · filed 2019-03-01
$1.31M
10-K · filed 2019-03-01
$986.00K
10-K · filed 2017-03-03
2016-09-30$80.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$579.00K
derived: sum of 2 quarters · filed 2017-11-08
$1.67M
10-Q · filed 2017-11-08
-$1.67M
10-Q · filed 2016-11-09
$2.19M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$499.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$1.59M
10-Q · filed 2017-08-09
-$1.59M
10-Q · filed 2016-08-10
$2.11M
derived: sum of 3 quarters · filed 2018-03-08
$2.15M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$1.09M
10-Q · filed 2017-05-15
-$1.09M
10-Q · filed 2016-05-13
$1.61M
derived: sum of 2 quarters · filed 2018-03-08
$1.65M
derived: sum of 3 quarters · filed 2018-03-08
$1.60M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$520.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$558.00K
derived: sum of 2 quarters · filed 2018-03-08
$515.00K
derived: sum of 3 quarters · filed 2018-03-08
$373.00K
10-K · filed 2018-03-08
2015-09-30$38.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$5.00K
derived: sum of 2 quarters · filed 2016-11-09
-$147.00K
10-Q · filed 2016-11-09
2015-06-30-$43.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
-$185.00K
10-Q · filed 2016-08-10
2015-03-31-$142.00K
10-Q · filed 2016-05-13
2014-12-31$88.00K
10-K · filed 2017-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
REGENXBIO Inc. (RGNX)United States$0.477B-3.30